APA (7th ed.) Citation

EP, L., CY, H., JF, C., L, B., L, H., P, B., . . . Y, S. (2022). Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 17(12), 1365. https://doi.org/10.1016/j.jtho.2022.08.010

Chicago Style (17th ed.) Citation

EP, Lin, et al. "Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 17, no. 12 (2022): 1365. https://doi.org/10.1016/j.jtho.2022.08.010.

MLA (9th ed.) Citation

EP, Lin, et al. "Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, vol. 17, no. 12, 2022, p. 1365, https://doi.org/10.1016/j.jtho.2022.08.010.